GTT (5 Sample – 75 Gram Glucose) at Test Zone Diagnostic Center

GTT (5 Sample – 75 Gram Glucose) at Test Zone Diagnostic Center

The Oral Glucose Tolerance Test (OGTT or GTT) with 5 samples and a 75-gram glucose load is a highly specialized, gold-standard diagnostic investigation used to evaluate the body’s efficiency in metabolizing carbohydrates. At Test Zone Diagnostic Center, this comprehensive metabolic assessment is performed under strictly controlled clinical conditions to ensure maximum diagnostic accuracy. Glucose is the primary source of energy for the body’s cells, and its levels in the bloodstream are tightly regulated by insulin, a hormone secreted by the beta cells of the pancreatic islets of Langerhans. When a patient consumes a standardized 75-gram oral glucose load, it triggers a physiological cascade: rapid absorption of glucose through the intestinal mucosa, a subsequent rise in blood glucose levels, and a compensatory release of insulin. This insulin facilitates the uptake of glucose into skeletal muscle and adipose tissue while suppressing hepatic glucose production. By measuring blood glucose levels at five distinct intervals—typically fasting (baseline), followed by measurements at 30 minutes, 60 minutes, 90 minutes, and 120 minutes post-ingestion—clinicians can construct a high-resolution glucose tolerance curve. This multi-sample approach offers far greater diagnostic sensitivity than a simple fasting blood sugar or a single postprandial test. It allows for the precise detection of subtle metabolic abnormalities, including impaired fasting glucose (IFG), impaired glucose tolerance (IGT), early-stage insulin resistance, type 2 diabetes mellitus, gestational diabetes, and reactive hypoglycemia. At Test Zone Diagnostic Center, we utilize advanced fully automated chemistry analyzers and follow stringent quality control protocols to deliver precise, reproducible results that empower physicians to design targeted therapeutic interventions.

Clinical Procedure: What to Expect

Patient Preparation

• Maintain an unrestricted diet containing at least 150 grams of carbohydrates per day for three days prior to the test to ensure metabolic enzymes are fully active.
• Fast strictly for 8 to 12 hours before the test. Only plain water is permitted during this fasting period; avoid tea, coffee, sodas, and juices.
• Avoid strenuous physical activity, heavy exercise, or training for 24 hours before the test, as physical exertion can temporarily alter insulin sensitivity and glucose clearance.
• Inform your physician about all medications you are currently taking. Certain drugs, such as corticosteroids, beta-blockers, thiazide diuretics, oral contraceptives, and atypical antipsychotics, can interfere with glucose metabolism.
• Refrain from smoking, chewing tobacco, or consuming alcohol for at least 24 hours prior to and during the entire duration of the test, as nicotine and alcohol significantly impact hepatic gluconeogenesis and insulin secretion.
• Remain seated and resting comfortably during the entire test period. Walking around or leaving the diagnostic center during the intervals can alter metabolic rates and invalidate the results.

During the Procedure

Upon arrival at Test Zone Diagnostic Center, the patient is guided to a comfortable phlebotomy chair where the initial baseline (fasting) blood sample is collected via venipuncture. The patient is then given a standardized solution containing 75 grams of anhydrous glucose dissolved in approximately 250-300 ml of water, which must be consumed entirely within 5 minutes. To ensure patient comfort and prevent nausea, the solution may be chilled or lightly flavored, as rapid ingestion of concentrated glucose can sometimes cause mild gastrointestinal discomfort. Following the ingestion of the glucose drink, the timer is started, and the patient must remain at rest in the waiting area. Subsequent blood samples are collected precisely at 30 minutes, 60 minutes, 90 minutes, and 120 minutes post-ingestion, totaling five venipunctures. Each sample is collected in specialized sodium fluoride/potassium oxalate (grey-top) tubes to inhibit glycolysis, ensuring that the glucose concentration remains stable until analysis. The patient’s safety is closely monitored throughout the procedure; any signs of severe nausea, vomiting, or hypoglycemic symptoms are promptly addressed by our clinical staff.

When is a GTT (5 Sample – 75 Gram Glucose) Performed?

Diagnosis of Type 2 Diabetes Mellitus

Physicians request this high-resolution test when fasting plasma glucose or HbA1c levels are borderline or inconclusive. The 5-sample GTT provides definitive diagnostic clarity by mapping the complete glucose clearance curve, showing how rapidly or slowly the body clears glucose from the bloodstream over a two-hour period.

Screening and Diagnosis of Gestational Diabetes

Pregnant individuals, typically between the 24th and 28th weeks of gestation, undergo this test to detect gestational diabetes mellitus (GDM). Identifying GDM is critical, as unmanaged maternal hyperglycemia can lead to macrosomia, preeclampsia, neonatal hypoglycemia, and other obstetric complications.

Identification of Impaired Glucose Tolerance (Pre-Diabetes)

The test is highly sensitive in identifying individuals with pre-diabetes, where glucose levels are elevated but do not yet meet the threshold for diabetes. Detecting this state allows for early lifestyle, dietary, or pharmacological interventions to prevent progression to full-blown type 2 diabetes.

Evaluation of Reactive Hypoglycemia

Patients experiencing symptoms of low blood sugar, such as sweating, palpitations, and shakiness, 2 to 4 hours after meals undergo this test. The 5-sample protocol helps observe if glucose levels drop abnormally low after an initial spike, indicating an exaggerated insulin response.

Assessment of Insulin Resistance and Metabolic Syndrome

Clinicians request this test for patients presenting with obesity, acanthosis nigricans, polycystic ovary syndrome (PCOS), or dyslipidemia. It helps evaluate the kinetics of glucose disposal and provides indirect insights into peripheral insulin sensitivity and pancreatic beta-cell reserve.

What Does a GTT (5 Sample – 75 Gram Glucose) Detect?

• Normal glucose tolerance with a physiological return to baseline within 120 minutes.
• Impaired Fasting Glucose (IFG), characterized by elevated baseline levels but normal post-load clearance.
• Impaired Glucose Tolerance (IGT), indicating delayed clearance at the 2-hour mark.
• Type 2 Diabetes Mellitus, confirmed by fasting or post-load values exceeding diagnostic thresholds.
• Gestational Diabetes Mellitus (GDM), diagnosed via specific pregnancy-related glycemic cutoffs.
• Reactive Hypoglycemia, demonstrated by a late-stage drop in blood glucose below normal fasting levels.
• Alimentary Hypoglycemia, often seen post-gastric surgery due to rapid glucose absorption and subsequent insulin surge.
• Delayed insulin response, characterized by an initial steep rise in glucose followed by a late, prolonged insulin release.
• Flat glucose curve, which may suggest malabsorption syndromes like celiac disease or hypopituitarism.
• Renal glycosuria, where glucose appears in urine despite normal blood glucose levels due to a low renal threshold.
• Insulin resistance associated with Polycystic Ovary Syndrome (PCOS).
• Secondary diabetes mellitus caused by endocrinopathies such as Cushing’s syndrome or acromegaly.
• Impaired glucose clearance due to chronic liver disease or hepatic cirrhosis.
• Pancreatogenic diabetes secondary to chronic pancreatitis or pancreatic insufficiency.
• Drug-induced glucose intolerance from long-term corticosteroid or diuretic therapy.
• Stress-induced hyperglycemia related to acute physical or psychological trauma.
• Early-stage beta-cell dysfunction, indicated by an abnormal peak at 30 or 60 minutes.
• Metabolic syndrome, characterized by a cluster of cardiovascular and glycemic abnormalities.
• Decreased peripheral insulin sensitivity in skeletal muscle tissue.
• Impaired hepatic insulin sensitivity, leading to inadequate suppression of gluconeogenesis.
• Subclinical carbohydrate intolerance in patients with unexplained peripheral neuropathy.
• Idiopathic postprandial syndrome, where symptoms mimic hypoglycemia without biochemical evidence.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand the importance of timely results for clinical decision-making. The GTT (5 Sample – 75 Gram Glucose) is processed using state-of-the-art automated chemistry analyzers, allowing us to deliver highly accurate results promptly. Reports are typically completed and verified by our consultant pathologists within 12 to 24 hours of sample collection. Patients can conveniently access their diagnostic reports online through the secure Test Zone Diagnostic Center web portal or mobile application. Additionally, physical copies of the reports can be collected directly from our main reception desk or received via our dedicated home delivery services where available.

GTT (5 Sample – 75 Gram Glucose) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Fasting Blood Glucose (0 Min)	Less than 100 mg/dL	100-125 mg/dL (Impaired Fasting Glucose); 126 mg/dL or higher (Diabetes)
30-Minute Blood Glucose	Typically less than 150 mg/dL	Markedly elevated levels indicating rapid absorption or delayed insulin release
60-Minute (1 Hour) Blood Glucose	Less than 180 mg/dL	180 mg/dL or higher (Early glucose intolerance or gestational diabetes marker)
90-Minute Blood Glucose	Less than 160 mg/dL	Persistent elevation indicating sluggish insulin action or peripheral resistance
120-Minute (2 Hours) Blood Glucose	Less than 140 mg/dL	140-199 mg/dL (Impaired Glucose Tolerance); 200 mg/dL or higher (Diabetes)
Urine Glucose (if co-tested)	Negative	Positive (Glycosuria, indicating blood glucose exceeded renal threshold)
Glucose Curve Shape	Smooth rise and fall	Flat curve (malabsorption) or steep spike with delayed decline (insulin resistance)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for GTT (5 Sample – 75 Gram Glucose)?

• Experienced healthcare professionals
• Patient-focused care
• Quality diagnostic services
• Professional reporting
• Modern diagnostic approach
• Comfortable environment
• Convenient location
• Commitment to accurate diagnosis